UltraSight Announces Partnership with Butterfly Garden AI-Marketplace

Stock.adobe.com

UltraSight is a digital health company working to improve cardiac imaging by using AI-powered technology. The company announced that it is joining the AI marketplace Butterfly Garden in an effort to increase patient access to cardiac care.¹ According to UltraSight, it will integrate and deploy its AI technology on the Butterfly platform and make it available for use with certain Butterfly products.

In a press release, UltraSight CEO Davidi Vortman said, “Joining the Butterfly Garden marks an important moment in our mission to revolutionize cardiac care. By integrating our real-time AI guidance software with Butterfly's cutting-edge ultrasound technology, we are poised to transform the landscape of cardiac imaging. This collaboration will empower healthcare professionals, regardless of their experience level, to perform accurate and timely cardiac ultrasound exams at the point of care. Together, we will break down existing barriers in cardiac care, ensuring that more patients receive the critical diagnostics they need, when and where they need it most."

In the same press release, Butterfly Network’s chief strategy officer Darius Shahida said, “We are thrilled to partner with UltraSight to bring their AI guidance software to Butterfly devices in an effort to mitigate the pressing issue of sonographer shortages, among other workforce challenges, impacting medical communities around the world. UltraSight and Butterfly are jointly dedicated to making healthcare more efficient, effective and accessible through high-quality ultrasound that's easy-to-use and globally available."

This is UltraSight’s latest partnership. Earlier this month, the company announced that it had partnered with the Mayo Clinic to use AI to advance the next generation of cardiac care.²

Paul Friedman, MD, is the chair of the department of cardiovascular medicine at the Mayo Clinic in Rochester, Minnesota. In a press release, he said, “According to the American Heart Association, the prevalence of cardiovascular disease is more than 75 percent in individuals over 60. Early detection may prevent the progression of heart disease or stroke.The addition of AI to point-of-care ultrasound, widely available and inexpensive, stands to eliminate significant barriers to adoption by guiding users in image acquisition and supporting image interpretation–making the approach highly scalable for early diagnosis and periodic cardiac monitoring."

In the same press release, Vortman said, “UltraSight Real-time Guidance software harnesses the power of AI to allow more medical practitioners to capture images with confidence. However, obtaining diagnostic quality cardiac images at the patient point of care is only the first step needed to increase patient access to quality care. We firmly believe that point-of-care ultrasound, when enhanced by the capabilities of AI, holds potential to optimize patient care. Through this collaboration, we plan to enhance our solution to detect and manage cardiac conditions in a more scalable and cost-effective way, ultimately helping more patients receive timely treatment."

Sources

1. UltraSight Joins Butterfly Garden to Expand AI Real-Time Guidance Across Point of Care Ultrasound Devices. UltraSight. June 27, 2024. https://www.prnewswire.com/news-releases/ultrasight-joins-butterfly-garden-to-expand-ai-real-time-guidance-across-point-of-care-ultrasound-devices-302184449.html
2. UltraSight Collaborates with Mayo Clinic to Advance Next Generation Cardiac Care with AI. UltraSight. June 3, 2024. Accessed June 27, 2024. https://www.prnewswire.com/news-releases/ultrasight-collaborates-with-mayo-clinic-to-advance-next-generation-cardiac-care-with-ai-302161460.html